Summary

The South American sleep apnea therapeutic devices market is undergoing substantial transformation, owing to many important regional factors. South America, which includes nations such as Brazil, Argentina, Colombia, and Chile, among others, has a thriving market for sleep apnea treatment devices in the middle of a changing healthcare landscape. The growing population's awareness and understanding of sleep disorders, especially sleep apnea, is a significant driver of market expansion. More people are seeking examination and treatment for sleep-related disorders as healthcare awareness campaigns gain hold and diagnostic capabilities grow. As a result of this increased awareness, an increasing number of sleep clinics, specialised centres, and healthcare facilities are offering sleep research and diagnostics, fueling the market for therapeutic equipment. Furthermore, South America is experiencing an increase in lifestyle-related health concerns, such as obesity and hypertension, both of which are known risk factors for sleep apnea. Changes in lifestyle, urbanisation, and stressful work situations all lead to disrupted sleep patterns, worsening the prevalence of sleep disorders. As a result, there is a growing demand for effective therapeutic devices for managing sleep apnea, urging healthcare professionals and politicians to prioritise accessible and creative solutions. The region's economic situation, while varying between countries, is experiencing expansion and urbanisation, leading to a growing middle class with better access to healthcare. As disposable incomes improve, people are more prepared to invest in healthcare, especially sleep-related treatments. Furthermore, government initiatives and healthcare policies aimed at improving public health and expanding healthcare infrastructure contribute to the growth and accessibility of sleep apnea therapeutic devices.

According to the research report "South America Sleep Apnea Therapeutic Devices Market Outlook, 2028," published by Bonafide Research, the South America Sleep Apnea Therapeutic Devices market is projected to add more than USD 400 Million from 2023 to 2028. South America is a heterogeneous region, with market patterns varying per country. Larger economies, such as Brazil and Argentina, have better developed healthcare infrastructures and higher market penetration of sleep apnea equipment than smaller economies. Understanding these regional differences is critical for market participants looking to develop a presence in South America. The regulatory environment in South America has a considerable impact on the market. Harmonising regulatory systems and aligning them with global standards is critical to facilitating the market introduction of novel devices and ensuring patient safety. The South American market provides chances for enterprises to create creative, localised solutions that address the region's specific demands and difficulties. Affordability strategies, patient education, and partnerships with local healthcare providers can aid in market expansion. The market is influenced by South America's demographic profile, which includes an ageing population and a growing middle class. The risk of sleep apnea grows with age, resulting in a greater demographic in need of therapeutic equipment. Furthermore, the growing middle class with increased disposable income contributes to rising healthcare spending and the desire for better treatment choices. Increased R&D spending, as well as strategic alliances between international firms and local entities, fuel innovation and market expansion. These alliances strive to create technologically innovative and cost-effective solutions for South America's diverse market. South America is seeing the rise of local manufacturing efforts. This trend encourages competition, creativity, and cost-effective localised solutions. Local manufacturers are critical to alleviating affordability issues and boosting market competitiveness.

In terms of the country report is divided into three major countries, Brazil, Argentina and Colombia. Among them Brazil is expected to dominate the South America sleep apnea therapeutic devices market.

Brazil has the most populated country in South America and a relatively sophisticated healthcare system in comparison to other countries in the region. This infrastructure comprises hospitals, clinics, and sleep centres that are equipped with the diagnostic instruments needed to evaluate sleep disorders. Brazil is seeing an increase in the prevalence of sleep disorders, particularly sleep apnea, as a result of changing lifestyles, rising obesity rates, and an ageing population. This increase in instances increases demand for diagnostic procedures and, as a result, therapeutic devices. Brazil is frequently a forerunner in the adoption of new technologies. This trend is extending to the healthcare industry, where developments in sleep apnea therapeutic equipment, such as the incorporation of smart features and telemedicine solutions, are being welcomed by both healthcare providers and patients. Government initiatives to improve healthcare services and expand access to medical facilities contribute to market growth. Supportive healthcare policies and investments in healthcare infrastructure further bolster the adoption of therapeutic devices for sleep apnea management. Brazil's research capabilities and clinical studies in the field of sleep medicine are gaining recognition. Collaborations between research institutions and healthcare providers pave the way for advancements in sleep disorder diagnosis and treatment.

Based on product market is bifurcated into positive airway pressure (PAP) device, adaptive servo-ventilation (ASV), airway clearance systems, oxygen devices, oral appliances, and others. Oral appliances are expected to grow at rapid pace in South America sleep apnea therapeutic devices market.

In comparison to continuous positive airway pressure (CPAP) equipment or surgery, oral appliances provide a non-invasive option for treating sleep apnea. Oral appliances are gaining popularity in South America, where patients prefer non-invasive treatments because of their comfort and convenience of usage. Continuous developments in oral appliance design aim to improve comfort, effectiveness, and compliance. These advancements, including customizable features and personalised fitting, help to improve patient results and boost acceptance of oral appliances. In South America, increasing awareness of the availability and effectiveness of oral appliances for sleep apnea therapy is boosting acceptance among both healthcare practitioners and patients. As more clinicians become familiar with these devices, they will prescribe them as an option or supplement to existing therapy. Oral appliances are frequently seen as more cost-effective in the long run than continuous usage of CPAP machines, especially when maintenance and replacement costs are considered. This element encourages patients to choose these devices, especially in areas where access to pricey medicines may be limited. These devices can be customised to meet the demands of each particular patient, resulting in a more personalised approach to treatment. The availability of competent dental specialists specialising in sleep medicine throughout South America makes these customised mouth appliances even more accessible.

Based on end user segment market includes, home care settings & individuals and sleep laboratories and hospitals. Among them home care settings & individuals are key end users of sleep apnea therapeutic devices market.

Individuals using sleep apnea treatment devices benefit from the ease and comfort of home care settings. Patients can manage their disease in the comfort of their own homes, ensuring better adherence to treatment regimens. Home-based care is consistent with the patient-centred approach to healthcare, allowing patients to actively engage in their care. Patients have more influence over their therapy, which can improve their overall experience and happiness with the treatment process. Advances in sleep apnea therapy devices have resulted in the creation of user-friendly, portable, and technologically advanced devices ideal for home usage. Remote monitoring and data collection capabilities further empower both patients and healthcare providers to track treatment progress. Individually tailored treatment strategies are possible with home-based care. Patients can get treatment while being remotely watched by healthcare specialists, allowing for prompt changes and personalised treatments as needed. Managing sleep apnea at home has a positive impact on mental health and quality of life. Reduced stress connected with hospital stays and the ability to retain regular habits help patients achieve better mental health outcomes. The growing reliance on telehealth services, particularly in post-pandemic circumstances, has increased the need for home-based care. Telemedicine allows for remote consultations, monitoring, and assistance, ensuring continuity of care for people living with sleep apnea.

Companies Covered in this report:
ResMed Inc. , Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Itamar Medical Ltd, Nihon Kohden Corporation, LivaNova, PLC , Cardinal Health, Inc.

Considered in this report:

• Geography: South America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• South America Sleep Apnea Therapeutic Devices market Outlook with its value and forecast along with its segments
• Country-wise Sleep Apnea Therapeutic Devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• Brazil
• Argentina
• Colombia

By Product:

• Positive Airway Pressure (PAP) Devices
• Adaptive Servo-Ventilation (ASV)
• Airway Clearance Systems
• Oxygen Delivery Products
• Oral Appliances
• Others

By End User:

• Home care Settings & Individuals
• Sleep laboratories & Hospitals

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Sleep Apnea Therapeutic Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.





***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents